Ivy Brain Tumor Center

Ivy Brain Tumor Center The largest Phase 0 Clinical Trials Program for aggressive brain cancer.

In compliance with federal and state privacy laws, please do not include any private health information in any message you send us through this channel.

New year, refined habits. Forget overwhelming resolutions; embrace small, sustainable steps for lasting well-being. This...
01/09/2026

New year, refined habits. Forget overwhelming resolutions; embrace small, sustainable steps for lasting well-being. This includes acknowledging our full range of emotions, as patient Jeff Muse shares: "Let it rip! Anger, sadness, fear—whatever you experience. Your shock and unexpected pain are real, but so is laughter, cheering, and feeling so driven by purpose and grit that you just might be more thankful for life than ever. All in one day!” By integrating these varied experiences, our habits truly support our overall health.

The Ivy Center is discovering tomorrow's treatments today through vital brain tumor research. Support our mission. Donat...
01/08/2026

The Ivy Center is discovering tomorrow's treatments today through vital brain tumor research. Support our mission. Donate now ➡️ https://bar.rw/45JQQzh

The Gray Matters Foundation is hosting its monthly online support group this Wednesday. Join us to support brain tumor s...
01/07/2026

The Gray Matters Foundation is hosting its monthly online support group this Wednesday. Join us to support brain tumor survivors and their caregivers.

January 14, 2026
4:00PM - 6:00PM (MST)
Click here to register: https://bar.rw/3N9cN4u

In early December, the Ivy Brain Tumor Center published a manuscript in Science Translational Medicine authored by Nader...
01/02/2026

In early December, the Ivy Brain Tumor Center published a manuscript in Science Translational Medicine authored by Nader Sanai, MD; Shwetal Mehta, PhD; Artak Tovmasyan, PhD; An-Chi Tien, PhD; Igor Barani, MD; Charuta Furey, MD; and Zaman Mirzadeh, MD, PhD, in collaboration with other Ivy Center team members. The manuscript presents results from our early-phase clinical trial utilizing sonodynamic therapy (SDT) in recurrent high-grade glioma patients. SDT pairs 5-aminolevulinic acid (5-ALA), which is metabolized to protoporphyrin IX in glioma cells, with noninvasive, image-guided focused ultrasound to trigger tumor-selective oxidative injury.

Click here to read: https://bar.rw/45sotFB

Thank you for a 2025 filled with shared dedication and remarkable community support. Your trust in the Ivy Brain Tumor C...
01/01/2026

Thank you for a 2025 filled with shared dedication and remarkable community support. Your trust in the Ivy Brain Tumor Center inspires our progress every day. Wishing you a New Year of health, happiness, and renewed hope! ✨

Happy Holidays from the Ivy Brain Tumor Center! Our team, strengthened by our shared collaborative spirit, had an amazin...
12/25/2025

Happy Holidays from the Ivy Brain Tumor Center! Our team, strengthened by our shared collaborative spirit, had an amazing time celebrating together. Wishing everyone a joyful and heartwarming season!✨

Earlier this month, we were inspired by the Midwestern University community, including student leaders like Brooke, who ...
12/24/2025

Earlier this month, we were inspired by the Midwestern University community, including student leaders like Brooke, who organized a 5K event to raise awareness for brain cancer. We appreciated the opportunity to connect with participants and recognize the shared commitment to awareness and support.

The Ivy Center is conducting a Phase 1/2 study evaluating the anti-cancer activity of emavusertib (CA-4948) alone or in ...
12/23/2025

The Ivy Center is conducting a Phase 1/2 study evaluating the anti-cancer activity of emavusertib (CA-4948) alone or in combination with ibrutinib in adults with relapsed or refractory hematologic malignancies.
🌐: https://bar.rw/4jucg9z
Talk to an Ivy Navigator today: 602-406-8605

Stay informed on the latest at the Ivy Brain Tumor Center. Our newsletter delivers updates directly to your inbox. Subsc...
12/22/2025

Stay informed on the latest at the Ivy Brain Tumor Center. Our newsletter delivers updates directly to your inbox. Subscribe here! ➡️ https://bar.rw/495ySbv

In honor of the holiday season, when you donate to the Ivy Brain Tumor Center, you directly empower the innovative resea...
12/13/2025

In honor of the holiday season, when you donate to the Ivy Brain Tumor Center, you directly empower the innovative research that's redefining glioblastoma treatment.

Donate today: https://bar.rw/4pwCn1v

This month, we are celebrating our December team member anniversaries. Your dedication and commitment to the Ivy Brain T...
12/12/2025

This month, we are celebrating our December team member anniversaries. Your dedication and commitment to the Ivy Brain Tumor Center's mission are truly inspiring. Thank you for another year of impactful contributions to brain tumor research and patient care! 💚

The Ivy Brain Tumor Center at Barrow Neurological Institute has clinical studies available for patients with glioblastom...
12/08/2025

The Ivy Brain Tumor Center at Barrow Neurological Institute has clinical studies available for patients with glioblastoma. Find out if our latest study is right for you or a loved one. Quisinostat is an investigational study drug.

🌐: https://bar.rw/48MoyVJ
☎️: 602.406.8605
✉️: Research@IvyBrainTumorCenter.org

Address

2910 North Third Avenue
Phoenix, AZ
85013

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16024066489

Alerts

Be the first to know and let us send you an email when Ivy Brain Tumor Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ivy Brain Tumor Center:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Ivy Brain Tumor Center

The Ivy Brain Tumor Center was founded to provide new avenues of hope for patients and families struggling with aggressive brain tumors. Our philosophy is to deploy scientifically rigorous and technologically advanced clinical trials that rapidly evaluate new therapeutic regimens and are tailored to exploit and attack individual tumor biologies.